Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1Phase 2 1

Status

Withdrawn 1Recruiting 1Completed 1

Sponsor Class

OTHER 2OTHER_GOV 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 3

Conditions

Lung Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Infections 1

Interventions

Carboplatin 346Cisplatin 240Paclitaxel 208Radiotherapy 207Pemetrexed 190Docetaxel 170Gemcitabine 158pembrolizumab 147Erlotinib Hydrochloride 111Magnetic Resonance Spectroscopy 102Etoposide 99Bevacizumab 96Specimen Handling 84Nivolumab 77Radiosurgery 74durvalumab 73Blood Specimen Collection 65Drug Therapy 61osimertinib 56Vinorelbine 54Gefitinib 50Surveys and Questionnaires 48atezolizumab 45Biopsy 43Radiation 42Irinotecan 42Topotecan 39Standard of Care 39Cyclophosphamide 38Surgical Procedures, Operative 35

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Lung Neoplasms × Dietary Supplements × Thoracic × Clear all
NCT06531460 2024-08-01

Nutritional Therapy Enriched With Omega-3 in Patients With Lung Resection

National Institute of Respiratory Diseases, Mexico

Phase NA Recruiting
310 enrolled
Thoracic

Infections, Lung Neoplasms

NCT04267874 2023-12-01

Black Raspberry Nectar for the Prevention of Lung Cancer, BE WELL Study

Ohio State University Comprehensive Cancer Center

Phase EARLY_PHASE1 Completed
96 enrolled
Thoracic

Lung Neoplasms

NCT03628144 2020-09-10

Immunonutrition to Reduce Toxicities in Non-Small Cell Lung Cancer

H. Lee Moffitt Cancer Center and Research Institute

Phase 2 Withdrawn
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡